Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 36% of BIOR shares are held by financial institutions. BARCLAYS PLC is the top corporate investor, holding 6.01K shares valued at $3.02K. A 0.16% stake in Biora Therapeutics, Inc. is owned by the company. STEWARD PARTNERS INVESTMENT ADVISORY, LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the BIOR insiders holding of 0.1% of the stake in company, HERSCHKOWITZ SAMUEL, 10 percent owner, holds the largest shares of 46.6M. STYLLI HARRY, Chairman & CEO, is the second largest BIOR insider with ownership of 14.62M shares. ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP, 10 percent owner, stands third with possession of 12.51M shares of that stake.
| Insiders | Designation | Shares Held |
|---|
| HERSCHKOWITZ SAMUEL | 10 percent owner | 46.6M |
| STYLLI HARRY | Chairman & CEO | 14.62M |
| ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP | 10 percent owner | 12.51M |
| ATHYRIUM CAPITAL MANAGEMENT, LP | 10 percent owner | 8.1M |
| ATHYRIUM OPPORTUNITIES FUND (A) LP | 10 percent owner | 8.1M |
| CARON PARTNERS LP | 10 percent owner | 6.16M |
| ROI PARTNERS L P | 10 percent owner | 302.57K |
| SILVESTRY DAMON | Chief Operating Officer | 197.48K |
| SARNA SURBHI | | 148.77K |
| MORGENS EDWIN H | director | 136.86K |
| COOPER MATTHEW T | Chief Scientific Officer | 53.43K |
| ALTER JEFFREY D. | director | 38.34K |
| WILLETT WILLIAM H | director | 10K |
| LARGIADER JEFF | VP Sales & Marketing | 2.5K |
| SIGHT JAMES W | director | 0 |
| WEINGARTEN ALLAN D | director | 0 |
